Primary Care Clinics in Richland Hills, TX Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 And Hyperbaric Medicine Center Of Grapevi Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 3901 Popplewell St Ste B, Richland Hills, TX 76118 Phone: 972-672-1269 |
Glenview Clinical Services Llc Internal Medicine Medicare: Medicare Enrolled Practice Location: 7640 Glenview Dr Ste C, Richland Hills, TX 76180 Phone: 817-284-0057 Fax: 817-284-1042 |
Mycommunitycenter Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7100 Boulevard 26 Ste 106, Richland Hills, TX 76180 Phone: 817-616-3413 Fax: 817-616-3388 |
Salam Al-hafidh Md Facp Pa Internal Medicine Medicare: Medicare Enrolled Practice Location: 7505 Glenview Dr Ste 151, Richland Hills, TX 76180 Phone: 817-284-9922 Fax: 817-284-9926 |
Centerwell Senior Primary Care- North Richland Hills Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7245 Boulevard 26, Richland Hills, TX 76180 Phone: 682-334-3648 Fax: 877-687-1917 |
Tarrant Community Pediatrics Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 7290 Glenview Dr, Richland Hills, TX 76180 Phone: 817-595-9944 Fax: 817-595-8835 |
News Archive
High levels of hygiene promote antibiotic resistance
The number of people who become ill and die from antibiotic-resistant germs is increasing worldwide. The World Health Organization WHO sees understanding the spread of antibiotic resistance and developing countermeasures as one of the most important global challenges.
Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules
Allergan plc, today announced that its subsidiaries Forest Laboratories, LLC and Forest Laboratories Holdings, Ltd., along with Adamas Pharmaceuticals, Inc., have entered into a settlement agreement with Amneal Pharmaceuticals LLC and related companies and subsidiaries.
BioSante Pharmaceuticals enters into securities purchase agreements with Great Point and Deerfield Management
BioSante Pharmaceuticals, Inc. today announced that it has received commitments from two institutional investors to purchase $18 million of securities in a registered direct offering. The investors are Great Point Partners, LLC and Deerfield Management Company. BioSante expects to receive net proceeds of approximately $17.5 million after deducting placement agent fees and other offering expenses.
Lynx2 gene linked to nervous behavior in mice
To measure anxiety in a mouse and suggest it's similar to anxiety in a person may seem like a stretch, but the metrics sound uncannily familiar.
Study: Weight loss linked with increased sleep duration
Obese adults who lose at least 5 percent of their body weight report that they sleep better and longer after six months of weight loss, according to a new study.
› Verified 2 days ago